title: Azeloglycine and nicotinamide down-regulate pro-inflammatory mediators in vitro.
authors.affiliation: Section of Dermatology, Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
authors.forename: Serena
authors.initials: S
authors.lastname: Lembo
authors.affiliation: Section of Dermatology, Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy - rob.dicaprio@libero.it.
authors.forename: Roberta
authors.initials: R
authors.lastname: DI Caprio
authors.affiliation: Section of Dermatology, Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
authors.forename: Anna
authors.initials: A
authors.lastname: Balato
authors.affiliation: Visufarma S.p.A, Rome, Italy.
authors.forename: Anna R
authors.initials: AR
authors.lastname: Bigioni
authors.affiliation: Section of Dermatology, Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
authors.forename: Giuseppina
authors.initials: G
authors.lastname: Caiazzo
authors.affiliation: Section of Dermatology, Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
authors.forename: Maria
authors.initials: M
authors.lastname: Schiattarella
authors.affiliation: Section of Dermatology, Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Monfrecola
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000494:pharmacology; D002460:Cell Line; D015536:Down-Regulation / Q000187:drug effects*; D005998:Glycine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism*; D009536:Niacinamide / Q000008:administration & dosage / Q000494:pharmacology*
chemical_list: D000893:Anti-Inflammatory Agents; D018836:Inflammation Mediators; C000617859:azeloglycine; D009536:Niacinamide; D005998:Glycine